Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the Pancreas

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Umeå University
75 trials monitored
See all monitored trials
Diabetes
5,141 trials monitored
See 246 trials at risk
Pancreatic Cancer
1,746 trials monitored
See 106 trials at risk
This prospective, single-center observational study investigates whether continuous glucose monitoring (CGM, 14 days) and gut microbiota composition (from a fecal sample) reveal patterns specific to pancreatic cancer, aiming to contribute to earlier detection and better assessment of disease severity. Adult patients under investigation, follow-up, or treatment for benign or malignant pancreatic/periampullary conditions are invited to participate in either or both parts of the study.
Trial Details
NCT Number NCT07843147
Lead Sponsor Umeå University
Collaborators: Region Västerbotten
Conditions
(from sponsor)		 Pancreatic Neoplasms, Pancreatic Cysts, Hyperglycemia, Prediabetes
Related terms Hyperglycemia, Pancreatic Cyst, Pancreatic Neoplasms, Prediabetic State
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov